In breast cancer, AHR activation reduces the proliferation of estrogen receptor-positive breast cancer cells, while both AHR agonists and antagonists have been reported to reduce colony formation, migration and metastasis of triple negative breast cancer cell lines (14, 15). The gene discussed is ESR1; the disease is breast cancer.